Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment

Authors Yaron Ilan.


Non-alcoholic steatohepatitis (NASH) is a common liver disorder worldwide. Although there has been improvement in our understanding of the natural history and pathogenesis of the disease, there is still no approved therapy for NASH. NASH shares many similarities with primary hypertension, in that both are extremely common disorders that can easily lead to serious complications if left untreated. Both conditions are viewed as “silent killers”, because the disease can progress over a period of time prior to the occurrence of potentially deadly outcomes. While attempts to find the “miracle pill” for NASH are unrealistic, we can make an analogy with the “stepwise combination” approach developed over the last few decades for the treatment of hypertension. In the present review, we summarize some of the similarities in the concepts that underlie NASH and hypertension. The development of a stepwise patient-tailored method for the treatment of NASH is presented.

Keywords Non-alcoholic steatohepatitis, hypertension, treatment, non-alcoholic fatty liver disease

Ann Gastroenterol 2018; 31 (3): 296-304

Review Articles